_ OUR NEWS
OCULUS BIOMED NEWS
November 1, 2023
OBM recently attended Australias premier biotechnology conference in Brisbane – represented by CEO Andrew Coloretti & Non-Executive Director Michelle Gallaher. The conference included valuable one-on-one private […]
October 9, 2023
Oculus BioMed (OBM) an ophthalmology focused biotechnology company, entered into a collaboration agreement with CERA – Centre for Eye Research Australia regarding the development of a therapeutic […]
October 1, 2023
OBM is delighted to welcome Michelle to the Board. She is an exceptional person and professional and brings significant industry experience and skill to the company. […]
August 28, 2023
OBM’s CEO was invited by Dr. Rupesh Agrawal – Deputy Research Head at Singapore’s Tan Tock Seng Hospital (TTSH) to tour the Ophthalmology department research facilities […]
August 28, 2023
OBM’s CEO & CSO held meetings with the company’s key business and scientific partners –ACRO Biomedical’s & Krisan Biotech CEO’s (D.J. Hsieh & Jamie Hung respectively) […]
July 30, 2023
Bio-Asia Taiwan is Asia’s largest biotech conference and networking event. OBM was invited by the Australian Government Trade Arm – Austrade to present at this event. OBM […]